What do you estimate that large and mid-tier pharmaceutical companies will spend on master data management (MDM) services and software from 2010 to 2012?
The money that pharma companies stand to save as a result of MDM will more than exceed their investments as long as they:
1. Deliberately plan their MDM programs. Successful MDM programs in pharma and health sciences mandate a requirements-driven, roadmap-enabled approach. This will also help with budgeting and resourcing -- ongoing challenges in many of these companies.
2. Apply rigor around their MDM investments. Pharma companies have a tendency to prefer vendors that are already in-house. We find that often translates into overinvestment.
Dig deeper on MDM best practices
Related Q&A from Jill Dyché, Partner and co-founder, Baseline Consulting
Is it better for companies to go with an enterprise-wide master data management (MDM) implementation or deploy MDM departmentally? Find out which ...continue reading
Is it a good idea to launch a data governance project without the help of a master data management (MDM) initiative? See what our MDM expert has to ...continue reading
Learn about the most common master data management (MDM) project pitfalls that companies run into. Get a list of the major problems that can hold ...continue reading
Have a question for an expert?
Please add a title for your question
Get answers from a TechTarget expert on whatever's puzzling you.